OssDsign Shares Update on PROPEL Spinal Fusion Study
Results show a fusion rate of 88.4% in a highly complex patient cohort, demonstrating that Catalyst nanosynthetic bone graft shows...
Results show a fusion rate of 88.4% in a highly complex patient cohort, demonstrating that Catalyst nanosynthetic bone graft shows...
PearlMatrix Bone Graft is the first and only bone growth accelerator proven to accelerate lumbar fusion....
OsteoFactor Pro is a blend of allogeneic growth factors engineered to improve bone healing and support surgical success across orthopedic...
The company reports confirmation of studies for MOTYS regenerative biologic, designed as an intra-articular injection for the management of symptomatic...
Summit will exclusively distribute NovaForm Wound Matrix, NovaBone’s bioglass and collagen-based wound dressing with application in orthopedic trauma repair....
Engineered with PureLoc Fiber Technology, Trivium combines synergistic elements intended to elevate performance in structure, handling, and biological activity....
The bone graft incorporating rhBMP-2 received FDA Investigational Device Exemption approval for a pivotal clinical trial in spinal fusion....
The limited release of Tempest DCF marks the company's entry into the cortical fiber segment of the spinal allograft market....
The Backpack Porous Biologic Scaffold is cleared for use in the intervertebral disc space, and is available in two versions....
BonVie+ is a calcium-salt resorbable bone void filler used to fill bone defects that is, with time, replaced by new...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.